tiprankstipranks
Cogent Biosciences (COGT)
NASDAQ:COGT
US Market

Cogent Biosciences (COGT) Balance Sheet

528 Followers

Cogent Biosciences Balance Sheet

Cogent Biosciences's total assets for Q1 2024 were $476.11M, an increase of 51.90% from the previous quarter. COGT total liabilities were $53.78M for the fiscal quarter, a -3.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 313.44M$ 300.81M$ 232.09M$ 250.92M$ 49.42M
Total Liabilities
$ 55.63M$ 45.08M$ 17.91M$ 16.25M$ 17.66M
Total Equity Gross Minority
$ 257.80M$ 255.74M$ 214.18M$ 234.67M$ 31.76M
Total Capitalization
$ 275.27M$ 255.74M$ 214.18M$ 234.67M$ 31.76M
Preferred Stock Equity
---$ 110.88M-
Capital Lease Obligations
---$ 5.21M$ 6.03M
Currency in USD

Cogent Biosciences Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis